Speakers

2022 HHT SCIENTIFIC CONFERENCE SPEAKERS

Michael Auerbach, MD, FACP

Auerbach Hematology and Oncology Associates, Inc.; Clinical Professor of Medicine, Georgetown University School of Medicine

Helen Arthur, PhD

Professor of Cardiovascular Biology, Biosciences Institute International Centre for Life; University of Newcastle, UK

Hans-Jurgen Mager, MD, PhD

Head of Netherlands Centre for HHT

Andrei Kindzelski, MD, PhD

Program Director, Division of Blood Diseases and Resources, NHLBI

Mark Vieth

Senior Vice President, CRD Associates

Roger Lewis, MD, PhD

Senior Medical Scientist, Berry Consultants, LLC

Mariona Graupera, PhD

Group Leader Endothelial Pathobiology and Microenvironment, Josep Carreras Leukaemia Research Institute

David R. Liu, PhD

Richard Merkin Professor; Director of the Merkin Institute of Transformative Technologies in Healthcare; Thomas Dudley Cabot Professor of the Natural Sciences; Professor of Chemistry and Chemical Biology, Harvard University

Capt. Robyn Bent, RN, MS

Director of the Patient-Focused Drug Development (PFDD) Program in the Center for Drug Evaluation and Research (CDER)

Kristina Bostrom, MD, PhD

Professor of Cardiology, David Geffen School of Medicine, UCLA

Waleed Brinjikji, MD

Professor of Radiology and Neurosurgery, Mayo Clinic College of Medicine

Marlene Rabinovitch, MD

Dwight and Vera Dunlevie Professor of Pediatric Cardiology, Stanford School of Medicine

Douglas Marchuk, PhD

James B, Duke Professor; Director, Division of Human Genetics, Duke Molecular Genetics and Microbiology, Duke University School of Medicine

Claudio A. Franco, PhD

Group Leader, Instituto de Medicina Molecular

Miles Conrad, MD, MPH

Co-Director, UCSF HHT Center of Excellence; Clinical Professor, Department of Radiology, University of California, San Francisco

William Sellers, MD

Core Institute Member for of the Cancer Program, Broad Institute of MIT and Harvard

Mickael Tanter, PhD

Research Professor Inserm; Director of Physics for Medicine Paris Lab (INSERM/ESPCI/CNRS); Director of the Inserm Accelerator for Technological Research in Biomedical Ultrasound, ESPCI Paris

Nicholas Benedict

Chief Executive Officer & Co-Founder of VADERIS Therapeutics Ltd.